Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial. Madison Muller has more on Bloomberg Television.

Officials are expected to talk next month about potential format and selection process changes (Yahoo) ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.